HEADER SIGNALING PROTEIN 07-MAR-18 6CN6 TITLE RORC2 LBD COMPLEXED WITH COMPOUND 34 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 6 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 7 ORPHAN RECEPTOR-GAMMA; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR RECEPTOR, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.KAUPPI,F.VAJDOS REVDAT 4 06-MAR-24 6CN6 1 REMARK REVDAT 3 01-MAY-19 6CN6 1 JRNL REVDAT 2 19-SEP-18 6CN6 1 JRNL REVDAT 1 05-SEP-18 6CN6 0 JRNL AUTH M.E.SCHNUTE,M.WENNERSTAL,J.ALLEY,M.BENGTSSON,J.R.BLINN, JRNL AUTH 2 C.W.BOLTEN,T.BRADEN,T.BONN,B.CARLSSON,N.CASPERS,M.CHEN, JRNL AUTH 3 C.CHOI,L.P.COLLIS,K.CROUSE,M.FARNEGARDH,K.F.FENNELL,S.FISH, JRNL AUTH 4 A.C.FLICK,A.GOOS-NILSSON,H.GULLBERG,P.K.HARRIS,S.E.HEASLEY, JRNL AUTH 5 M.HEGEN,A.E.HROMOCKYJ,X.HU,B.HUSMAN,T.JANOSIK,P.JONES, JRNL AUTH 6 N.KAILA,E.KALLIN,B.KAUPPI,J.R.KIEFER,J.KNAFELS,K.KOEHLER, JRNL AUTH 7 L.KRUGER,R.G.KURUMBAIL,R.E.KYNE JR.,W.LI,J.LOFSTEDT, JRNL AUTH 8 S.A.LONG,C.A.MENARD,S.MENTE,D.MESSING,M.J.MEYERS, JRNL AUTH 9 L.NAPIERATA,D.NOTEBERG,P.NUHANT,M.J.PELC,M.J.PRINSEN, JRNL AUTH10 P.RHONNSTAD,E.BACKSTROM-RYDIN,J.SANDBERG,M.SANDSTROM,F.SHAH, JRNL AUTH11 M.SJOBERG,A.SUNDELL,A.P.TAYLOR,A.THORARENSEN,J.I.TRUJILLO, JRNL AUTH12 J.D.TRZUPEK,R.UNWALLA,F.F.VAJDOS,R.A.WEINBERG,D.C.WOOD, JRNL AUTH13 L.XING,E.ZAMARATSKI,C.W.ZAPF,Y.ZHAO,A.WILHELMSSON,G.BERSTEIN JRNL TITL DISCOVERY OF 3-CYANO- JRNL TITL 2 N-(3-(1-ISOBUTYRYLPIPERIDIN-4-YL) JRNL TITL 3 -1-METHYL-4-(TRIFLUOROMETHYL)-1 H-PYRROLO[2,3- JRNL TITL 4 B]PYRIDIN-5-YL)BENZAMIDE: A POTENT, SELECTIVE, AND ORALLY JRNL TITL 5 BIOAVAILABLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR JRNL TITL 6 C2 INVERSE AGONIST. JRNL REF J. MED. CHEM. V. 61 10415 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30130103 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00392 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 12980 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 664 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2591 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2195 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2483 REMARK 3 BIN R VALUE (WORKING SET) : 0.2177 REMARK 3 BIN FREE R VALUE : 0.2622 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.17 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 108 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1879 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 91 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.95510 REMARK 3 B22 (A**2) : 5.95510 REMARK 3 B33 (A**2) : -11.91020 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.297 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.330 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.238 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.300 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.232 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2005 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2736 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 731 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 46 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 322 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2005 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 241 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2300 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.48 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.84 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6CN6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1000233042. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 243204 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 138.250 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 18.60 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS PH 8.7, 27% ETHANOL, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.08400 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 92.16800 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 69.12600 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 115.21000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 23.04200 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 46.08400 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 92.16800 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 115.21000 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 69.12600 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 23.04200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 259 REMARK 465 PRO A 260 REMARK 465 GLU A 261 REMARK 465 ALA A 262 REMARK 465 PRO A 263 REMARK 465 TYR A 264 REMARK 465 GLN A 495 REMARK 465 ALA A 496 REMARK 465 ALA A 497 REMARK 465 PHE A 498 REMARK 465 PRO A 499 REMARK 465 PRO A 500 REMARK 465 LEU A 501 REMARK 465 TYR A 502 REMARK 465 LYS A 503 REMARK 465 GLU A 504 REMARK 465 LEU A 505 REMARK 465 PHE A 506 REMARK 465 SER A 507 REMARK 465 THR A 508 REMARK 465 GLU A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 SER A 512 REMARK 465 PRO A 513 REMARK 465 VAL A 514 REMARK 465 GLY A 515 REMARK 465 LEU A 516 REMARK 465 SER A 517 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 286 -66.19 71.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A4189 DISTANCE = 6.44 ANGSTROMS REMARK 525 HOH A4190 DISTANCE = 7.63 ANGSTROMS REMARK 525 HOH A4191 DISTANCE = 7.81 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F7J A 4000 DBREF 6CN6 A 259 517 UNP P51449 RORG_HUMAN 259 517 SEQADV 6CN6 SER A 278 UNP P51449 CYS 278 ENGINEERED MUTATION SEQADV 6CN6 SER A 345 UNP P51449 CYS 345 ENGINEERED MUTATION SEQRES 1 A 259 THR PRO GLU ALA PRO TYR ALA SER LEU THR GLU ILE GLU SEQRES 2 A 259 HIS LEU VAL GLN SER VAL SER LYS SER TYR ARG GLU THR SEQRES 3 A 259 CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN ARG SER SEQRES 4 A 259 ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR GLN ARG SEQRES 5 A 259 LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA HIS HIS SEQRES 6 A 259 LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS SEQRES 7 A 259 ARG LEU SER GLY PHE MET GLU LEU SER GLN ASN ASP GLN SEQRES 8 A 259 ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL VAL LEU SEQRES 9 A 259 VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN ARG THR SEQRES 10 A 259 VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU LEU PHE SEQRES 11 A 259 ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER ILE PHE SEQRES 12 A 259 ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SER GLU SEQRES 13 A 259 ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU ILE ASN SEQRES 14 A 259 ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU SEQRES 15 A 259 GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS SEQRES 16 A 259 LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA LYS LEU SEQRES 17 A 259 PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER GLN HIS SEQRES 18 A 259 VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE SEQRES 19 A 259 VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS GLU LEU SEQRES 20 A 259 PHE SER THR GLU THR GLU SER PRO VAL GLY LEU SER HET F7J A4000 67 HETNAM F7J 3-CYANO-N-{3-[1-(CYCLOPENTANECARBONYL)PIPERIDIN-4-YL]- HETNAM 2 F7J 1,4-DIMETHYL-1H-INDOL-5-YL}BENZAMIDE FORMUL 2 F7J C29 H32 N4 O2 FORMUL 3 HOH *91(H2 O) HELIX 1 AA1 SER A 266 CYS A 285 1 20 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 LYS A 311 1 11 HELIX 5 AA5 SER A 312 ARG A 337 1 26 HELIX 6 AA6 SER A 345 MET A 365 1 21 HELIX 7 AA7 GLY A 384 GLY A 392 5 9 HELIX 8 AA8 CYS A 393 ALA A 409 1 17 HELIX 9 AA9 SER A 413 ILE A 426 1 14 HELIX 10 AB1 GLU A 435 THR A 457 1 23 HELIX 11 AB2 SER A 461 LEU A 466 1 6 HELIX 12 AB3 PRO A 468 HIS A 490 1 23 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SSBOND 1 CYS A 455 CYS A 455 1555 10664 2.07 SITE 1 AC1 18 CYS A 285 GLN A 286 LEU A 287 CYS A 320 SITE 2 AC1 18 HIS A 323 LEU A 324 MET A 365 ARG A 367 SITE 3 AC1 18 ALA A 368 VAL A 376 PHE A 377 PHE A 388 SITE 4 AC1 18 LEU A 396 ILE A 400 PHE A 401 SER A 404 SITE 5 AC1 18 HIS A 479 HOH A4106 CRYST1 90.840 90.840 138.252 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011008 0.006356 0.000000 0.00000 SCALE2 0.000000 0.012711 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007233 0.00000